financetom
Business
financetom
/
Business
/
--Merck Discontinuing Phase 3 Trials of Keytruda in Non-Small Cell Lung Cancer, Skin Cancer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Merck Discontinuing Phase 3 Trials of Keytruda in Non-Small Cell Lung Cancer, Skin Cancer
Aug 29, 2024 4:07 AM

06:40 AM EDT, 08/29/2024 (MT Newswires) --

Price: 117.00, Change: -0.40, Percent Change: -0.34

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved